Recent News

• 10.02.2025 - Quince Therapeutics 2025 Virtual Investor Day
• 10.02.2025 - Quince Therapeutics 2025 Virtual Investor Day
• 09.11.2025 - Quince Therapeutics to Host Virtual Investor Day on October 2, 2025
• 09.11.2025 - Quince Therapeutics to Host Virtual Investor Day on October 2, 2025
• 09.05.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.05.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.02.2025 - Quince Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
• 09.02.2025 - Quince Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
• 08.11.2025 - Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
• 08.11.2025 - Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Recent Filings

• 08.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.11.2025 - EX-99.1 EX-99.1
• 08.11.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.11.2025 - 8-K Current report
• 08.05.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 08.05.2025 - EFFECT Notice of Effectiveness